Literature DB >> 9710173

Impairment level sumscore in reflex sympathetic dystrophy of one upper extremity.

H M Oerlemans1, R J Goris, R A Oostendorp.   

Abstract

OBJECTIVES: To construct a set of instruments to measure the level of impairment in reflex sympathetic dystrophy (RSD), to convert the scores for each instrument into one score and to derive a compounded impairment level sumscore (ISS), and to evaluate reliability, validity, and responsiveness of the ISS. DATA SOURCES AND EXTRACTION: Literature search in Medline (1985 to 1995), non-Medline journals, and references from these reports for measurement parameters and suitable, reliable, responsive, and validated instruments. DATA SYNTHESIS: Four measurement parameters (pain, active range of motion, temperature, and volume) and five measurement instruments were chosen to construct the ISS. All outcomes were converted into one score, resulting in an addable score.
RESULTS: Forty-five patients with RSD of one upper extremity were evaluated. As expected for this heterogeneous index, the internal consistency of the ISS was poor to moderate. The ISS seemed to have content and concurrent validity. The responsiveness of the ISS was adequate.
CONCLUSIONS: A multicomponent test was constructed to map alterations in the level of impairment in RSD patients. Each of the parameter scores could be translated into a uniform score. Adding the scores yielded the ISS.

Entities:  

Mesh:

Year:  1998        PMID: 9710173     DOI: 10.1016/s0003-9993(98)90098-3

Source DB:  PubMed          Journal:  Arch Phys Med Rehabil        ISSN: 0003-9993            Impact factor:   3.966


  6 in total

1.  Clinical Characteristics and Patient-Reported Outcomes of Primary Care Physiotherapy in Patients with Whiplash-Associated Disorders: A Longitudinal Observational Study.

Authors:  Rob A B Oostendorp; J W Hans Elvers; Emiel van Trijffel; Geert M Rutten; Gwendolyne G M Scholten-Peeters; Marcel Heijmans; Erik Hendriks; Emilia Mikolajewska; Margot De Kooning; Marjan Laekeman; Jo Nijs; Nathalie Roussel; Han Samwel
Journal:  Patient Prefer Adherence       Date:  2020-09-28       Impact factor: 2.711

2.  Cost effectiveness and cost utility of acetylcysteine versus dimethyl sulfoxide for reflex sympathetic dystrophy.

Authors:  Hiske E M van Dieten; Roberto S G M Perez; Maurits W van Tulder; Jaap J de Lange; Wouter W A Zuurmond; Herman J Ader; Hindrik Vondeling; Maarten Boers
Journal:  Pharmacoeconomics       Date:  2003       Impact factor: 4.981

3.  The effectiveness and cost evaluation of pain exposure physical therapy and conventional therapy in patients with complex regional pain syndrome type 1. Rationale and design of a randomized controlled trial.

Authors:  Karlijn J Barnhoorn; Rob A B Oostendorp; Robert T M van Dongen; Frank P Klomp; Han Samwel; Gert Jan van der Wilt; Eddy Adang; Hans Groenewoud; Henk van de Meent; Jan Paul M Frölke
Journal:  BMC Musculoskelet Disord       Date:  2012-04-19       Impact factor: 2.362

4.  Increased endothelin-1 and diminished nitric oxide levels in blister fluids of patients with intermediate cold type complex regional pain syndrome type 1.

Authors:  J George Groeneweg; Frank J P M Huygen; Claudia Heijmans-Antonissen; Sjoerd Niehof; Freek J Zijlstra
Journal:  BMC Musculoskelet Disord       Date:  2006-11-30       Impact factor: 2.362

5.  Pain exposure physical therapy (PEPT) compared to conventional treatment in complex regional pain syndrome type 1: a randomised controlled trial.

Authors:  Karlijn J Barnhoorn; Henk van de Meent; Robert T M van Dongen; Frank P Klomp; Hans Groenewoud; Han Samwel; Maria W G Nijhuis-van der Sanden; Jan Paul M Frölke; J Bart Staal
Journal:  BMJ Open       Date:  2015-12-01       Impact factor: 2.692

6.  Pain Exposure Physical Therapy versus conventional treatment in complex regional pain syndrome type 1-a cost-effectiveness analysis alongside a randomized controlled trial.

Authors:  Karlijn Barnhoorn; J Bart Staal; Robert Tm van Dongen; Jan Paul M Frölke; Frank P Klomp; Henk van de Meent; Eddy Adang; Maria Wg Nijhuis-van der Sanden
Journal:  Clin Rehabil       Date:  2018-02-12       Impact factor: 3.477

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.